Affinity Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Affinity Investment Advisors's LLY Position: Q3 2026 in Review
Affinity Investment Advisors reduced its Eli Lilly (LLY) stake by 4.2% in Q3 2026, selling an estimated $17.7K and leaving 345 shares worth $399K. The position accounts for 0.17% of the portfolio, ranked #106.
Affinity Investment Advisors first reported a position in LLY in Q3 2024 and has held it in 9 quarters since. The position peaked at $432K in Q2 2026. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Affinity Investment Advisors held 345 shares of Eli Lilly worth $399K as of Q3 2026.
- Affinity Investment Advisors sold 15 Eli Lilly shares in Q3 2026, an estimated $17.7K.
- Eli Lilly made up 0.17% of Affinity Investment Advisors's portfolio in Q3 2026, its #106 holding.
- Affinity Investment Advisors first reported a position in Eli Lilly in Q3 2024 and has held it in 9 quarters since.
- Affinity Investment Advisors's Eli Lilly position peaked at $432K in Q2 2026.
- 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Affinity Investment Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.